跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
K-18
首页
药物
K-18
K-18
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING
申请人: BIO IMAGING KOREA CO LTD
优先权: 2018
CN
Intrauterine contraceptive device
申请人: KARPATI MELINDA-KINGA
优先权: 2006
CN
EP
US
4 件公开
Cyclin K degradation agent
申请人: ADLAI NORTYE BIOPHARMA CO LTD
优先权: 2021
CN
Cell necrosis signal identifying type intelligent adminisration carrier
申请人: UNIV SICHUAN
优先权: 2004
CN
18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precu
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
CN
Application of 18 beta-glycyrrhetinic acid in preparation of medicine for relaxing pulmonary artery blood vessels
申请人: UNIV NINGXIA MEDICAL
优先权: 2022
CN
Double-Acylated GLP-1 Derivatives
申请人: MADSEN ALICE RAVN
优先权: 2010
CN
US
6 件公开
DOUBLE-ACYLATED GLP-1 DERIVATIVES
申请人: NOVO NORDISK AS
优先权: 2009
CN
US
4 件公开
药物
反馈